RCS - Brandshield Systems - Contract Win

Brandshield SystemsAnnouncement

06/04/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220406:nRSF3884Ha&default-theme=true

RNS Number : 3884H  Brandshield Systems PLC  06 April 2022

6 April 2022

 

BrandShield Systems plc

 

("BrandShield," the "Company," or the "Group")

 

Contract Win

 

BrandShield secures mandate with global pharmaceutical company

 

BrandShield Systems plc (AIM: BRSD), a leading provider of cybersecurity
solutions for brand oriented digital risk protection, is pleased to announce
that it has secured a new business contract with a leading pharmaceutical
company ('the Client'). This comes as part of an ongoing growth in sales and
the closing of several new customers since the beginning of 2022.

BrandShield will provide advanced brand protection for the Client, deploying
its highly automated SaaS offering to identify and eradicate online threats,
including fake pharmacies.

Geographically, BrandShield will focus on utilising its innovative software
services to prevent cybercriminals across Asia and Oceania from jeopardising
the Client's operations, alongside safeguarding users and improving the
experience of the Client's customer base.

 

The mandate expands BrandShield's portfolio of pharmaceutical clients, which
includes partnerships with the Pharmaceutical Security Institute and Bristol
Myers Squibb, where BrandShield has leveraged its unique capabilities to
detect and remove rogue pharmacies and fraudulent drug listings from the
online space.

 

Yoav Keren, Chief Executive Officer of BrandShield, commented:

 

"This win is an example of one of several new mandates BrandShield has already
secured in 2022, strengthening our reputation as a leading provider of digital
risk protection solutions for companies across a wide array of sectors.

 

"BrandShield has a proven track record of successfully identifying and
eradicating critical online threats to global pharmaceutical companies and we
look forward to extending our leading position in the pharmaceutical space,
one of many exciting opportunities in our pipeline for the near to medium
term."

 

 

Enquiries:

 

 BrandShield Systems plc                              +44 (0)20 3143 8300

 Yoav Keren, CEO

 Spark Advisory Partners Limited (Nominated Adviser)  +44 (0)20 3368 3554

 Neil Baldwin / Andrew Emmott / James Keeshan

 Shore Capital (Joint Broker)                         +44 (0)20 7408 4090

 Toby Gibbs / James Thomas (Corporate Advisory)

 Henry Willcocks (Corporate Broking)

 Tennyson Securities (Joint Broker)                   +44 (0)20 3368 3554

 Peter Krens

 Vigo Consulting (Financial Public Relations)         +44 (0)20 7390 0237

 Jeremy Garcia / Kendall Hill / Tara Benniman

 brandshield@vigoconsulting.com

 

 

About BrandShield

BrandShield is a leading cybersecurity company founded in Israel by
cybersecurity experts that protect the world's largest brands and consumers
from phishing attacks, online fraud, and other online threats posed by
dangerous cybercriminals. Through its AI/ML platform, BrandShield identifies,
tracks, and eliminates online threats for global brands and organizations,
including Bristol Myers Squibb, Levi's, NewBalance, Swisscom, and the
Pharmaceutical Security Institute. BrandShield is quoted on the London Stock
Exchange AIM under ticker symbol BRSD. To learn more about BrandShield, please
visit the company website at www.BrandShield.com (http://www.BrandShield.com)
.

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and
unlisted (including AIM quoted) companies to distribute media only /
non-regulatory news releases such as marketing messages, corporate and product
information into the public domain. An RNS Regulatory announcement is required
to be notified under the AIM Rules for Companies.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABKPBKOBKDNQK